<DOC>
	<DOCNO>NCT02592889</DOCNO>
	<brief_summary>Functional mitral regurgitation ( FMR ) common find patient dilate cardiomyopathy reduce leave ventricular ejection fraction ( LVEF ) . The presence relevant FMR ( grade ≥2 ) associate high morbidity mortality . Cardiac resynchronization therapy ( CRT ) show effective patient dilate cardiomyopathy reduce LVEF . In selected patient , CRT link clinical improvement reduce mortality . Importantly , 38 % patient clinical indication CRT present moderate severe ( FMR ) . Although FMR might reduce CRT , persistence relevant FMR ( ≥2 ) CRT range 40 % 50 % independent predictor clinical response . In patient , surgical FMR correction frequently turn result high surgical risk . Percutaneous repair mitral valve MitraClip system demonstrate promising result patient dilate cardiomyopathy reduce LVEF5 . In cohort patient response CRT FMR ≥2 , Auricchio et al show significant clinical improvement LVEF recovery reduction leave ventricle ( LV ) volumes MitraClip . The absence randomization , retrospective nature study subsequent selection bias however major limitation impede solid conclusion . The objective present study ass efficacy safety MitraClip system non-responders CRT FMR ≥2 .</brief_summary>
	<brief_title>( MitraClip Non-Responders Cardiac Resynchronization Therapy )</brief_title>
	<detailed_description>STUDY HYPOTHESIS : In patient response CRT significant FMR ( grade ≥2 , 100 % ) , MitraClip system associate improved functional class , LVEF recovery reduce LV volume . To knowledge , register randomized study similar design conduct . MAIN OBJECTIVE : To compare efficacy safety optimal medical treatment MitraClip versus optimal medical treatment alone ( control ) non-responders CRT symptomatic FMR ≥2 .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>1 . CRT implant 6 month 5 year inclusion . 2 . Absence clinical response CRT define baseline NYHA 3 NYHA 2 hospital admission HF within last 12 month . 3 . Adequate CRT therapy ( correct stimulation &gt; 98 % heart beat ) . 4 . Correct position cardiac lead . 5 . Patients atrial fibrillation include balanced group ( presence AF independent factor clinical response ) . 6 . Wide QRS ( &gt; 0.12 ) LBBB preCRT . 7 . LVEF 1540 % ( surgical risk criterion ) . 8 . Left ventricle enddiastolic diameter &lt; 75 mm ( anatomical criterion MitraClip feasibility ) . 1 . Severe Renal Insufficiency ( DFGe &lt; 30 ) . 2 . Life expectancy &lt; 1 year . 3 . Anatomical contraindication MitraClip ( order avoid selection bias , patient must Mitraclip candidate ) . 4 . Hemodynamic instability inclusion define SBP &lt; 70 mmHg need inotropic treatment within previous 3 month . 5 . Inadequate treatment compliance difficult followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>MITRAL REGURGITATION</keyword>
</DOC>